Lianyungang, China

Xiaojin Wang


 

Average Co-Inventor Count = 11.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Xiaojin Wang: Innovator in Pharmaceutical Science

Introduction

Xiaojin Wang is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of inhibitors for capsid protein assembly. With a total of seven patents to his name, his work has the potential to impact the treatment of diseases caused by viral infections.

Latest Patents

Xiaojin Wang's latest patents include innovative compounds designed to inhibit capsid protein assembly. One notable patent is for an N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, which includes a pharmaceutical composition and its medical uses. This invention specifically targets diseases caused by hepatitis B virus infection, providing a promising avenue for treatment. Another patent focuses on a similar compound, emphasizing its pharmaceutical composition and medical applications in treating related diseases.

Career Highlights

Throughout his career, Xiaojin Wang has worked with notable companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Xiaojin Wang has collaborated with esteemed colleagues in his field, including Hongjiang Xu and Yinsheng Zhang. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Xiaojin Wang is a distinguished inventor whose work in pharmaceutical science is paving the way for new treatments for viral infections. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…